Last Updated: 14 Nov 2024
Executive Summary
Ekso Bionics Holdings Inc. (EKSO) is a medical technology company that designs, develops, sells, and rents exoskeleton products. The company has a market capitalization of $16.9 million and trades on the NASDAQ exchange. EKSO's latest stock price is $0.77.
Company Overview
Ekso Bionics was founded in 2005 and is headquartered in Richmond, California. The company's products are used to help people with mobility impairments walk, stand, and climb stairs. EKSO's customers include hospitals, rehabilitation centers, and individuals.
Fundamental Analysis
EKSO's financial performance has been mixed in recent years. The company has reported losses in each of the past three years. However, revenue has grown in each of the past two years. In 2022, EKSO reported revenue of $17.7 million, up 10.4% from 2021.
EKSO's gross profit margin has also improved in recent years. In 2022, the company's gross profit margin was 38.2%, up from 34.5% in 2021. However, EKSO's operating margin and net income margin remain negative.
Technical Analysis
EKSO's stock price has been in a downtrend since early 2023. The stock has fallen from a high of $3.13 in January 2023 to a low of $0.73 in July 2023. The stock is currently trading below its 50-day and 200-day moving averages.
Short Term Outlook
The technical analysis suggests that EKSO's stock price could continue to decline in the short term. The stock is trading below its key moving averages and is in a downtrend. However, the stock could rebound if it can break above resistance at $1.00.
Long Term Outlook
The long-term outlook for EKSO is more positive. The company's products have the potential to help millions of people with mobility impairments. EKSO is also well-positioned to benefit from the growing demand for exoskeleton products.
Analyst Recommendations
Two analysts have issued buy ratings on EKSO in the past three months. The average analyst target price is $5.50.
